Okada CY - Search Results

1

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.

Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R. Timmerman JM, et al. Among authors: okada cy. Blood. 2002 Mar 1;99(5):1517-26. doi: 10.1182/blood.v99.5.1517. Blood. 2002. PMID: 11861263 Free article. Clinical Trial.

2

Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma.

Reichardt VL, Okada CY, Stockerl-Goldstein KE, Bogen B, Levy R. Reichardt VL, et al. Among authors: okada cy. Biol Blood Marrow Transplant. 1997 Aug;3(3):157-63. Biol Blood Marrow Transplant. 1997. PMID: 9310193 Review.

3

TCR vaccines for active immunotherapy of T cell malignancies.

Okada CY, Wong CP, Denney DW, Levy R. Okada CY, et al. J Immunol. 1997 Dec 1;159(11):5516-27. J Immunol. 1997. PMID: 9548492

4

TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.

Wong CP, Okada CY, Levy R. Wong CP, et al. Among authors: okada cy. J Immunol. 1999 Feb 15;162(4):2251-8. J Immunol. 1999. PMID: 9973501

5

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.

Reichardt VL, Okada CY, Liso A, Benike CJ, Stockerl-Goldstein KE, Engleman EG, Blume KG, Levy R. Reichardt VL, et al. Among authors: okada cy. Blood. 1999 Apr 1;93(7):2411-9. Blood. 1999. PMID: 10090953 Free article. Clinical Trial.

6

Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas.

Lossos IS, Okada CY, Tibshirani R, Warnke R, Vose JM, Greiner TC, Levy R. Lossos IS, et al. Among authors: okada cy. Blood. 2000 Mar 1;95(5):1797-803. Blood. 2000. PMID: 10688840 Free article.

7

T cell antigen receptor vaccines for active therapy of T cell malignancies.

Reddy SA, Okada C, Wong C, Bahler D, Levy R. Reddy SA, et al. Ann N Y Acad Sci. 2001 Sep;941:97-105. doi: 10.1111/j.1749-6632.2001.tb03714.x. Ann N Y Acad Sci. 2001. PMID: 11594586 Free article.

8

TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection.

Lambert SL, Okada CY, Levy R. Lambert SL, et al. Among authors: okada cy. J Immunol. 2004 Jan 15;172(2):929-36. doi: 10.4049/jimmunol.172.2.929. J Immunol. 2004. PMID: 14707065

9

Gene expression and angiotropism in primary CNS lymphoma.

Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M. Rubenstein JL, et al. Blood. 2006 May 1;107(9):3716-23. doi: 10.1182/blood-2005-03-0897. Epub 2006 Jan 17. Blood. 2006. PMID: 16418334 Free PMC article.

10

Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.

Halwani AS, Panizo C, Isufi I, Herrera AF, Okada CY, Cull EH, Kis B, Chaves JM, Bartlett NL, Ai W, de la Cruz-Merino L, Bryan LJ, Houot R, Linton K, Briones J, Chau I, von Keudell GR, Lu H, Yakovich A, Chen M, Meulen Jh T, Yurasov S, Hsu FJ, Flowers CR. Halwani AS, et al. Among authors: okada cy. Leuk Lymphoma. 2022 Apr;63(4):821-833. doi: 10.1080/10428194.2021.2010057. Epub 2021 Dec 6. Leuk Lymphoma. 2022. PMID: 34865586 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters